MedTrace Logo

Incidence of Venous Thromboembolism in Patients With Pelvic and Acetabular Fractures (PAF)

NCT07165587 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2025-09-10

No results posted yet for this study

Summary

The goal of this observational study is to investigate the incidence of venous thromboembolism (VTE) in patients with pelvic and acetabular fractures (PAF). The main question it aims to answer is:

What is the incidence of VTE in PAF patients receiving standardized thromboprophylaxis with enoxaparin 4,000 IU twice daily?

Participants admitted with a pelvic, acetabular, or combined fracture receive thromboprophylaxis as part of their routine clinical care. All participants undergo bilateral duplex ultrasound screening during hospitalization to detect both symptomatic and asymptomatic deep vein thrombosis. If pulmonary embolism is clinically suspected, computed tomography pulmonary angiography is performed.

The study aims to provide prospective observational data on VTE incidence and its association with fracture type, patient risk profile, and treatment modality.

Conditions

  • Pelvic Fractures
  • Acetabular Fractures
  • Pelvic Trauma
  • Venous Thromboembolic Event
  • Venous Thromboembolism
  • Thromboprophylaxis
  • Pulmonary Embolism and Thrombosis

Interventions

DIAGNOSTIC_TEST

Bilateral duplex ultrasonography

Bilateral duplex ultrasound screening performed during hospitalization to detect symptomatic and asymptomatic deep vein thrombosis in patients with pelvic and acetabular fractures.

Sponsors & Collaborators

  • Department of Trauma and Reconstructive Surgery at Eberhard Karls University Tuebingen, BG Klinik Tu

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07165587 on ClinicalTrials.gov